These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21481946)

  • 21. Atypical antipsychotic drugs and Alzheimer's disease.
    Jockers-Scherübl MC; Hellweg R
    N Engl J Med; 2007 Jan; 356(4):416-7; author reply 417-8. PubMed ID: 17256186
    [No Abstract]   [Full Text] [Related]  

  • 22. Clozapine-induced sialorrhea alleviated by bupropion--a case report.
    Stern RG; Bellucci D; Cursi-Vogel N; Hughley J; Elangovan N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1578-80. PubMed ID: 19800381
    [No Abstract]   [Full Text] [Related]  

  • 23. Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
    Bobo WV; Jayathilake K; Lee MA; Meltzer HY
    Hum Psychopharmacol; 2009 Jul; 24(5):415-22. PubMed ID: 19551763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comment: unanticipated plasma concentrations in two clozapine-treated patients.
    Lu ML; Lane HY; Chang WH
    Ann Pharmacother; 2001 Dec; 35(12):1675-6. PubMed ID: 11793646
    [No Abstract]   [Full Text] [Related]  

  • 25. Exploring clozapine pharmacokinetics in Tunisian schizophrenic patients: A population-based modelling approach investigating the impact of genetic and non-genetic variables.
    Mansour K; Fredj NB; Ammar H; Romdhane HB; Mhalla A; Chaabane A; Chadli Z; Aouam K
    Basic Clin Pharmacol Toxicol; 2024 Jun; 134(6):805-817. PubMed ID: 38599832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clozapine-responsive cluster headache.
    Datta SS; Kumar S
    Neurol India; 2006 Jun; 54(2):200-1. PubMed ID: 16804270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine in China.
    Tang YL; Mao PX; Jiang F; Chen Q; Wang CY; Cai ZJ; Mitchell PB
    Pharmacopsychiatry; 2008 Jan; 41(1):1-9. PubMed ID: 18203045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term efficacy and tolerability of clozapine combined with ziprasidone or risperidone.
    Kuwilsky A; Krumm B; Englisch S; Dressing H; Zink M
    Pharmacopsychiatry; 2010 Aug; 43(6):216-20. PubMed ID: 20589598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequencies of four genetic polymorphisms in the CYP1A2 gene in Turkish population.
    Bilgen T; Tosun O; Luleci G; Keser I
    Genetika; 2008 Aug; 44(8):1133-6. PubMed ID: 18825963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine use in Australia.
    Malalagama G; Bastiampillai T; Dhillon R
    Australas Psychiatry; 2011 Apr; 19(2):175. PubMed ID: 21443399
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism.
    Tiwari AK; Deshpande SN; Lerer B; Nimgaonkar VL; Thelma BK
    Pharmacogenomics J; 2007 Oct; 7(5):305-11. PubMed ID: 16969362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible levomepromazine-clozapine interaction: two case reports.
    Bugamelli F; Mandrioli R; Kenndler E; Bartoletti C; Boncompagni G; Raggi MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):567-70. PubMed ID: 17174461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salivary flow rate in patients with schizophrenia on clozapine.
    Praharaj SK; Jana AK; Goswami K; Das PR; Goyal N; Sinha VK
    Clin Neuropharmacol; 2010 Jul; 33(4):176-8. PubMed ID: 20661023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and conventional antipsychotic drugs].
    Galvez-Buccollini JA; Fiestas F; Herrera P; Vega-Dienstmaier JM; Guimas B; Mazzotti G
    Actas Esp Psiquiatr; 2004; 32(4):211-5. PubMed ID: 15232749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flexibilization in controlling the use of clozapine: A great opportunity.
    Álvarez de Morales Gómez-Moreno E; Muquebil Ali Al Shaban Rodríguez OW; Fernández Fernández J; Fresno García C
    Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(4):255-256. PubMed ID: 29486914
    [No Abstract]   [Full Text] [Related]  

  • 37. Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice.
    Aitchison KJ; Jann MW; Zhao JH; Sakai T; Zaher H; Wolff K; Collier DA; Kerwin RW; Gonzalez FJ
    J Psychopharmacol; 2000; 14(4):353-9. PubMed ID: 11198052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine Metabolism in East Asians and Caucasians: A Pilot Exploration of the Prevalence of Poor Metabolizers and a Systematic Review.
    Ruan CJ; Zang YN; Wang CY; Cheng YH; Sun C; Spina E; de Leon J
    J Clin Psychopharmacol; 2019; 39(2):135-144. PubMed ID: 30811372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clozapine access project.
    Grace JJ; Szarowicz RS
    Psychiatr Serv; 2001 Jan; 52(1):108. PubMed ID: 11141542
    [No Abstract]   [Full Text] [Related]  

  • 40. Is there a future for
    Ruan CJ; de Leon J
    Pharmacogenomics; 2020 Apr; 21(6):369-373. PubMed ID: 32308139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.